Back

Unobserved automated office blood pressure measurement in the Systolic Blood Pressure Intervention Trial (SPRINT): systolic blood pressure treatment target remains below 140 mmHg

European Heart Journal - Cardiovascular Pharmacotherapy

27 January 2016
Organised by: Logo
Read full article
ESC Journals

Contributors

Sverre E. Kjeldsen
Sverre E. Kjeldsen

Author

Oslo University Hospital Ulleval Oslo , Norway

Giuseppe Mancia
Giuseppe Mancia

Author

You may be interested in
thumbnail
Congress Presentation
Different systolic blood pressure targets and outcomes: a systematic review and meta-analysis of randomized trials
28 August 2023
thumbnail
Webinar
Blood pressure measurement at the time of Covid-19. The role of home blood pressure monitoring
25 January 2021
thumbnail
Congress Presentation
Automated blood pressure measurements: optimal diastolic blood pressure range in treated hypertensives at high cardiovascular risk.
31 August 2019
thumbnail
Congress Presentation
Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources